• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

加拿大乳腺癌女性接受辅助放疗的自付费用。

Out-of-pocket costs for accessing adjuvant radiotherapy among Canadian women with breast cancer.

机构信息

Centre Hospitalier Affilié Universitaire de Québec, Québec, Québec, Canada.

出版信息

J Clin Oncol. 2011 Oct 20;29(30):4007-13. doi: 10.1200/JCO.2011.35.1007. Epub 2011 Sep 19.

DOI:10.1200/JCO.2011.35.1007
PMID:21931023
Abstract

PURPOSE

Patients with breast cancer incur out-of-pocket costs when they receive adjuvant radiation. These treatments are administered in dedicated centers on a daily basis over 4 to 5 weeks. We assessed the extent of out-of-pocket costs to access radiotherapy and identified women at risk of experiencing higher costs.

PATIENTS AND METHODS

This prospective study was conducted among 800 women from eight Quebec hospitals (participation, 86%), of whom 693 women received adjuvant radiotherapy. Costs to access treatment (transportation, parking, lodging, and meals) were estimated on the basis of information collected by telephone interviews. Generalized linear models were used to identify women at risk of having higher costs.

RESULTS

Mean and median total costs (including financial aid received) to access radiotherapy were 445 Canadian dollars (Can$; standard deviation, Can$407) and Can$311, respectively. Women who lived at home but far from the radiotherapy center had the highest risk of experiencing weekly costs of at least Can$122 (highest quartile; prevalence ratio [PR], 5.8; 95% CI, 4.7 to 7.1) followed by women who lived away from home and farther from the center (PR, 4.5; 95% CI, 3.4 to 6.0) and by women who lived away from home and closer to the center (PR, 2.14; 95% CI, 1.3 to 3.5). When women stayed at a cancer lodge during treatment, costs were reduced by 80%.

CONCLUSION

Considered in and of themselves, out-of-pocket costs for access to radiotherapy appeared relatively modest. Financial assistance initiatives for women who lived away from home during treatments contributed to a substantial reduction of access costs. These efforts should be maintained, but financial assistance should also target patients with cancer who live at home during treatments but have to travel relatively long distances on a daily basis.

摘要

目的

接受辅助放疗的乳腺癌患者需要自掏腰包。这些治疗需要在专门的中心进行,每天治疗一次,持续 4 到 5 周。我们评估了获得放疗的自付费用的程度,并确定了有更高费用风险的女性。

患者和方法

这是一项在魁北克八家医院的 800 名女性中进行的前瞻性研究(参与率 86%),其中 693 名女性接受了辅助放疗。根据电话访谈收集的信息,估算了获得治疗的费用(交通、停车、住宿和餐饮)。使用广义线性模型确定有更高费用风险的女性。

结果

接受放疗的总费用(包括收到的经济援助)的平均值和中位数分别为 445 加元(标准差为 407 加元)和 311 加元。那些住在家里但离放疗中心很远的女性,每周至少要花费 122 加元(最高四分位数;患病率比 [PR],5.8;95%置信区间,4.7 至 7.1)的风险最高,其次是那些不住在家里且离中心更远的女性(PR,4.5;95%置信区间,3.4 至 6.0)和那些不住在家里且离中心更近的女性(PR,2.14;95%置信区间,1.3 至 3.5)。当女性在治疗期间住在癌症旅舍时,费用降低了 80%。

结论

仅从自身来看,获得放疗的自付费用相对较低。为那些在治疗期间不住在家里的女性提供的财务援助举措有助于大幅降低获得治疗的费用。应维持这些努力,但财务援助也应针对那些在治疗期间住在家里但每天需要长途旅行的癌症患者。

相似文献

1
Out-of-pocket costs for accessing adjuvant radiotherapy among Canadian women with breast cancer.加拿大乳腺癌女性接受辅助放疗的自付费用。
J Clin Oncol. 2011 Oct 20;29(30):4007-13. doi: 10.1200/JCO.2011.35.1007. Epub 2011 Sep 19.
2
Out-of-pocket costs in the year after early breast cancer among Canadian women and spouses.加拿大女性及其配偶在早期乳腺癌后一年的自付费用。
J Natl Cancer Inst. 2013 Feb 20;105(4):280-92. doi: 10.1093/jnci/djs512. Epub 2013 Jan 24.
3
Patient costs associated with external beam radiotherapy treatment for localized prostate cancer: the benefits of hypofractionated over conventionally fractionated radiotherapy.局限性前列腺癌外照射放疗治疗的患者费用:与常规分割放疗相比,大分割放疗的益处
Can J Urol. 2012 Apr;19(2):6165-9.
4
The financial burden of cancer: estimates from a study of insured women with breast cancer.癌症的经济负担:一项针对参保乳腺癌女性的研究估算
J Support Oncol. 2004 May-Jun;2(3):271-8.
5
Attitudes of Canadian radiation oncologists towards post-lumpectomy radiotherapy for elderly women with stage I hormone-responsive breast cancer.加拿大放射肿瘤学家对激素反应性Ⅰ期乳腺癌老年女性保乳术后放疗的态度。
Clin Oncol (R Coll Radiol). 2010 Mar;22(2):97-106. doi: 10.1016/j.clon.2009.10.001. Epub 2009 Nov 1.
6
Costs and determinants of privately financed home-based health care in Ontario, Canada.加拿大安大略省私人资助的居家医疗保健的成本与决定因素
Health Soc Care Community. 2008 Mar;16(2):126-36. doi: 10.1111/j.1365-2524.2007.00732.x.
7
Hypofractionated whole-breast radiotherapy: impact on departmental waiting times and cost.大分割全乳放疗:对科室等待时间和成本的影响。
J Med Imaging Radiat Oncol. 2010 Jun;54(3):229-34. doi: 10.1111/j.1754-9485.2010.02163.x.
8
Family and out-of-pocket costs for women with breast cancer.乳腺癌女性的家庭和自付费用。
Cancer Pract. 1994 May-Jun;2(3):187-93.
9
Investigating the correlation between hospital of primary treatment and the survival of women with breast cancer.研究初次治疗医院与乳腺癌女性患者生存率之间的相关性。
Cancer. 2005 Oct 1;104(7):1343-8. doi: 10.1002/cncr.21336.
10
Conceptualization and sources of costs from breast cancer: findings from patient and caregiver focus groups.乳腺癌成本的概念化及来源:患者和护理人员焦点小组的研究结果
Psychooncology. 2005 May;14(5):351-60. doi: 10.1002/pon.851.

引用本文的文献

1
Cost-Effectiveness of Pembrolizumab With Chemoradiotherapy for Locally Advanced Cervical Cancer.帕博利珠单抗联合放化疗治疗局部晚期宫颈癌的成本效益分析
JAMA Netw Open. 2025 Mar 3;8(3):e250033. doi: 10.1001/jamanetworkopen.2025.0033.
2
Cost-effectiveness of durvalumab plus tremelimumab in combination with chemotherapy for the treatment of metastatic non-small-cell lung cancer from the US healthcare sector's and societal perspectives.从美国医疗保健部门和社会角度看,度伐利尤单抗联合曲美木单抗与化疗联合用于治疗转移性非小细胞肺癌的成本效益。
Front Pharmacol. 2024 Jun 10;15:1256992. doi: 10.3389/fphar.2024.1256992. eCollection 2024.
3
Patient and Family Financial Burden in Cancer: A Focus on Differences across Four Provinces, and Reduced Spending Including Decisions to Forego Care in Canada.
癌症患者及其家庭的经济负担:以加拿大四个省份的差异为重点,并包括减少医疗开支和放弃治疗的决策。
Curr Oncol. 2024 May 11;31(5):2713-2726. doi: 10.3390/curroncol31050206.
4
Proximity to Radiotherapy Center, Population, Average Income, and Health Insurance Status as Predictors of Cancer Mortality at the County Level in the United States.美国县一级的癌症死亡率的预测因子:靠近放射治疗中心、人口数量、平均收入和健康保险状况。
JCO Glob Oncol. 2023 Sep;9:e2300130. doi: 10.1200/GO.23.00130.
5
The many "costs" of transportation: Examining what cancer caregivers experience as transportation obstacles.交通的诸多“代价”:探究癌症照护者在交通方面所面临的障碍。
Cancer Med. 2023 Aug;12(16):17356-17364. doi: 10.1002/cam4.6351. Epub 2023 Jul 23.
6
Pembrolizumab vs cemiplimab for the treatment of advanced non-small cell lung cancer with PD-L1 expression levels of at least 50%: A network meta-analysis and cost-effectiveness analysis.帕博利珠单抗对比西米普利单抗治疗PD-L1表达水平至少为50%的晚期非小细胞肺癌:一项网状Meta分析和成本效益分析
Front Oncol. 2022 Sep 26;12:878054. doi: 10.3389/fonc.2022.878054. eCollection 2022.
7
Cost-effectiveness of ipilimumab versus high-dose interferon as an adjuvant therapy in resected high-risk melanoma.依匹单抗对比大剂量干扰素作为辅助治疗用于高风险黑色素瘤根治术后的成本效果分析。
Cancer Med. 2021 Oct;10(19):6618-6626. doi: 10.1002/cam4.4194. Epub 2021 Aug 17.
8
Cost-effectiveness of Nivolumab-Ipilimumab Combination Therapy for the Treatment of Advanced Non-Small Cell Lung Cancer.纳武利尤单抗联合伊匹单抗治疗晚期非小细胞肺癌的成本效果分析。
JAMA Netw Open. 2021 May 3;4(5):e218787. doi: 10.1001/jamanetworkopen.2021.8787.
9
Patient and family financial burden associated with cancer treatment in Canada: a national study.加拿大癌症治疗相关的患者和家庭经济负担:一项全国性研究。
Support Care Cancer. 2021 Jun;29(6):3377-3386. doi: 10.1007/s00520-020-05907-x. Epub 2021 Jan 5.
10
A theoretical model of financial burden after cancer diagnosis.癌症诊断后的经济负担理论模型。
Future Oncol. 2020 Dec;16(36):3095-3105. doi: 10.2217/fon-2020-0547. Epub 2020 Sep 25.